INFECTIOUS DISEASES AND INTERNATIONAL SECURITY

Abstract

Threats to the security of states can result from the deliberate use of pathogens (biological weapons), their accidental release from research laboratories, or naturally occurring outbreaks of particular infectious diseases. This article discusses emerging opportunities for international cooperation against infectious diseases through the Biological Weapons Convention (BWC) and the World Health Organization (WHO). The new process for reviewing the BWC could shift the BW problem away from the traditional arms control paradigm and toward broader notions of disease-based threats to security. In addition, proposed revisions to the WHO's International Health Regulations are highly relevant to the challenge of responding to emerging and re-emerging infectious diseases through national and international mechanisms. The article concludes with recommendations for meeting emerging BW threats.

Keywords:

• Biological weapons
• Emerging infectious diseases
• World Health Organization

Acknowledgments

The author thanks Robert Ayson and the NPR reviewers for comments on an earlier draft.

Notes

1. Roland Paris, “Human Security: Paradigm Shift or Hot Air?” International Security 26 (2001), p. 95.

2. Livy (trans. by Aubrey de Selincourt), The War with Hannibal (London: Penguin, 1965), pp. 331–32.

3. Shannon Selin, “The Security Implications of SARS,” CANCAPS Bulletin, No. 37 (2003), p. 10.

4. Susan Peterson, “Epidemic Disease and National Security,” Security Studies 12 (2002), p. 70.

5. Michael Moodie, Reducing the Biological Threat: New Thinking, New Approaches (Washington DC: Chemical and Biological Arms Control Institute, 2003), p. 42.

6. Yue Sie Wong and Gregory Chan, “The SAF SARS Diaries,” in Pointer Supplement (Singapore: Singapore Armed Forces, 2004), p. 33.

7. Elizabeth M. Prescott, “SARS: A Warning,” Survival 45, (Sept. 2003), p. 209.

8. John Bolton, Statement to the Fifth Review Conference of the Biological Weapons Convention, (Geneva: Fifth Review Conference of the States Parties to the Convention on the Development, Production and Stockpiling of Bacteriological (Biological) and Toxin Weapons and On Their Destruction, 2001).

9. Fifth Review Conference of the States Parties to the Convention on the Development, Production and Stockpiling of Bacteriological (Biological) and Toxin Weapons and On Their Destruction, Final Document, BWC/CONF.V/17, Geneva, Nov. 22, 2002, pp. 3–4.

10. See, for example, Amy Smithson, “Biological Weapons: Can Fear Overwhelm Inaction?” Washington Quarterly 28 (Winter 2004–5), p. 171; Alexander Kelle, “Strengthening the Effectiveness of the BTW Control Regime–Feasibility and Options,” Contemporary Security Policy 24 (Aug. 2003), p. 127; and Jonathan B. Tucker, “The New BWC Process: A Preliminary Assessment,” Nonproliferation Review 11 (Spring 2004), p. 11.

11. Christopher F. Chyba and Alex L. Greninger, “Biotechnology and Bioterrorism: An Unprecedented World,” Survival 46 (2004), p. 144.

12. Moodie, Reducing the Biological Threat, p. 24.

13. Pete Moore, Killer Germs: Rogue Diseases of the Twenty-First Century (London: Carlton, 2001), p. 1.

14. Meeting of the States Parties to the Convention on the Development, Production and Stockpiling of Bacteriological (Biological) and Toxin Weapons and On Their Destruction, Report of the Meeting of States Parties, Volume 1, BWC/MSP/2003/4 (Vol. 1), Geneva, Nov. 26, 2003, p. 5.

15. David Murphy, “Lab Bungle,” Far Eastern Economic Review, May 6, 2004, p. 18.

16. Marilyn W. Thompson, “The Pursuit of Steven Hatfill,” Washington Post, Sept. 14, 2003, p. W06.

17. Scott Shane, “Bioterror Fight May Spawn New Risks,” Baltimore Sun June 27, 2004, <www.baltimoresun.com/news/nationworld/balte.biodefense27jun27,0,6098679.story>.

18. See Kathryn Weathersby, “Deceiving the Deceivers: Moscow, Beijing, Pyongyang, and the Allegations of Bacteriological Weapons Use in Korea,” Cold War International History Project Bulletin, No. 11 (Winter 1998), and Jonathan B. Tucker, “The ‘Yellow Rain’ Controversy: Lessons for Arms Control Compliance,” Nonproliferation Review 8 (Spring 2001), pp. 25–42.

19. The WHO publication, Public health response to biological and chemical weapons: WHO guidance, addresses procedures to respond to BW use and recounts lessons learned from historical incidents where BW have been used. Available at <www.who.int/csr/delibepidemics/biochemguide/en/>.

20. United Nations, “A More Secure World: Our Shared Responsibility,” report of the Secretary-General's High-Level Panel on Threats, Challenges and Change, 2004, p. 47, <www.un.org/secureworld/report3.pdf>.

21. Jennifer Brower and Peter Chalk, The Global Threat of New and Reemerging Infectious Diseases: Reconciling U.S. National Security and Public Health Policy (Santa Monica, CA: RAND, 2003), p. xviii.

22. Moodie, Reducing the Biological Threat, p. 41.

23. “US Develops Lethal New Viruses,” New Scientist Website, Oct. 29, 2003, <www.newscientist.com/news/news.jsp?id = ns99994318>.

24. Nicholas A. Sims, “The New Multilateral Approach for the BTWC: Ambiguities and Opportunities,” Strengthening the Biological Weapons Convention: Briefing Paper No. 2 (2nd series), Dept. of Peace Studies, University of Bradford, Bradford UK, Jan. 2003, p. 13.

25. Chyba and Greninger, “Biotechnology and Bioterrorism,” pp. 152–53.

26. Meeting of the States Parties to the Convention on the Development, Production and Stockpiling of Bacteriological (Biological) and Toxin Weapons and On Their Destruction, Report of the Meeting of States Parties, BWC/MSP/2004/3, Geneva, Dec. 14, 2004, p. 5.

27. Statement on Behalf of the Non-Aligned Movement and Other State,” Fifth Review Conference of the States Parties to the Convention on the Development, Production and Stockpiling of Bacteriological (Biological) and Toxin Weapons and On Their Destruction, Geneva, Nov. 14, 2002).

28. Christian Enemark, Disease Security in Northeast Asia: Biological Weapons and Natural Plagues (Canberra: Australian National University, 2004), p. 1.

29. Jacques de Lisle, “SARS, Greater China, and the Pathologies of Globalisation and Transition,” Orbis 58 (Fall 2003), pp. 588 and 601, and Yanzhong Huang, Mortal Peril: Public Health in China and Its Security Implications (Washington, DC: Chemical and Biological Arms Control Institute, 2003), p. 72.

30. Constitution of the World Health Organization, July 22, 1946, p. 1, <www.yale.edu/lawweb/avalon/decade/decad051.htm>.

31. Lawrence O. Gostin, “International Infectious Disease Law: Revision of the World Health Organization's International Health Regulations,” JAMA 291 (2004), p. 2624.

32. WHO, “Revision of the International Health Regulations,” WMA56.28, Fifty-Sixth World Health Assembly, Geneva, 2003, <www.who.int/gb/ebwha/pdf_files/WHA56/ea56r28.pdf>.

33. Gostin, “International Infectious Disease Law,” p. 2625.

34. WHO, “Revision Process of the International Health Regulations,” <www.who.int/csr/ihr/revision/en/>.

35. Gostin, “International Infectious Disease Law,” p. 2625.

36. Gostin, “International Infectious Disease Law,” pp. 2625–26.

37. Gostin, “International Infectious Disease Law,” p. 2626.

38. Statement by Australia, Technical Assistance, Exchange and Cooperation Undertaken by Australia in the Field of Biotechnology, Fifth Review Conference of the States Parties to the Convention on the Development, Production and Stockpiling of Bacteriological (Biological) and Toxin Weapons and On Their Destruction, Geneva, Oct. 26, 2001, pp. 3, 5.

39. See Alan Dupont, East Asia Imperilled: Transnational Challenges to Security (Cambridge, U.K.: Cambridge University Press, 2001); P. W. Singer, “AIDS and International Security,” Survival 44 (March 2002), pp. 145–58; and Stefan Elbe, Strategic Implications of HIV/AIDS, Adelphi Paper 357 (New York: Oxford University Press, 2003).

40. Peter Piot, Richard G. A. Feachem, Jong-wook Lee, and James D. Wolfensohn, “A Global Response to AIDS: Lessons Learned, Next Steps,” Science 304 (2004), p. 1910.

41. Jon Cohen, “The Next Frontier for HIV/AIDS: Myanmar,” Science 301 (2003), p. 1651.

42. Dupont, East Asia Imperilled, p. 220.

43. David P. Fidler, “Germs, Norms and Power: Global Health's Political Revolution,” Law, Social Justice & Global Development 1 (2004), pp. 11–12.

44. David P. Fidler, “Germs, Norms and Power: Global Health's Political Revolution,” Law, Social Justice & Global Development 1 (2004), p. 12.

45. David P. Fidler, “Germs, Norms and Power: Global Health's Political Revolution,” Law, Social Justice & Global Development 1 (2004), p. 13.

46. Commission on Human Security, Human Security Now (New York: Commission on Human Security, 2003), p. 106; “Mechanisms Being Implemented for Response to Outbreaks of Disease by Intergovernmental Organizations (World Health Organization (W.H.O.), Food and Agriculture Organization (F.A.O.), World Organization for Animal Health/Office International des Epizooties (O.I.E.)” Meeting of Experts from States Parties to the Convention on the Prohibition of the Development, Production and Stockpiling of Bacteriological (Biological) and Toxin Weapons and on Their Destruction, Geneva, July 1, 2004, p. 7.

47. David L. Heymann and Guenael R. Rodier, “Hot Spots in a Wired World: WHO Surveillance of Emerging and Re-Emerging Infectious Diseases,” Lancet Infectious Diseases 1 (2001), p. 347.

48. David Lague, “Stopping a Killer,” Far Eastern Economic Review, Feb. 5, 2004, pp. 15–16.

49. “Thailand Announces First Death from Bird Flu,” Sydney Morning Herald, Jan. 24, 2004, <www.smh.com.au/articles/2004/01/24/1074732634150.html>.

50. WHO, “Cumulative Number of Confirmed Human Cases of Avian Influenza A (H5N1) since 28 January 2004,” Jan. 13, 2005, <www.who.int/csr/disease/avian_influenza/country/cases_table_2005_01_13/en/>.

51. Dept. of Defense, “CBDP 2003 Annual Report to Congress,” 2003, pp. ii–iii.

52. Jonathan B. Tucker, “Biological Threat Assessment: Is the Cure Worse Than the Disease?” Arms Control Today 34 (Oct. 2004), p. 14.

53. Jonathan B. Tucker, “A Farewell to Germs: The U.S. Renunciation of Biological and Toxin Warfare, 1969–70,” International Security 27 (2002), pp. 145–46.

54. Barbara Hatch Rosenberg, “Defending against Biodefence: The Need for Limits,” Acronym Institute, Jan. 2003, <www.acronym.org.uk/bw#c/spec01.htm>.

55. Tucker, “Biological Threat Assessment,” p. 17.

56. Tucker, “Biological Threat Assessment,” pp. 15–16, and Tucker, “A Farewell to Germs,” p. 148.

57. Jennifer Brower and Peter Chalk, “Vectors without Borders: The Spread of Global Pathogens Can Imperil Us All,” RAND Review, 27 (Summer 2003), <www.rand.org/publications/randreview/issues/summer2003/vectors.html>.

58. “Covering the Parts Other Bioshields Don't Reach,” Lancet Infectious Diseases 4 (2004), p. 1.